June 2002                                  

From: SIDMAK

It is my pleasure to announce that Sidmak Laboratories, Inc., and its wholly owned subsidiary, Odyssey Pharmaceuticals, Inc., have been acquired by PLIVA d.d., Croatia.

PLIVA, the largest pharmaceutical company in Central and Eastern Europe, is a unique company with investments in both research and development (R&D).  With recent acquisitions of pharmaceutical and R&D companies in Poland, the Czech Republic, France, Germany, Denmark, and the UK, PLIVA is in possession more than 400 patents, and with development of new chemical entity (NCE) and generic pharmaceutical products PLIVA is well-positioned for sustained growth.

With the acquisition of Sidmak and Odyssey, PLIVA will now have its first major presence in the USA.  Although it has licensed several products to major American pharmaceutical companies- particularly with its discovery of the macrolide antibiotic azithromycin- to date PLIVA has not been involved directly with the manufacture, sales, or distribution of finished products for human use within the USA.

This exciting and timely acquisition by PLIVA will strengthen the Sidmak tradition of marketing innovative, high-quality, and timely new products.  It is a perfect fit with the strategic goals, direction, and vision that have been developed for Sidmak and Odyssey.  PLIVA will facilitate Sidmak becoming a leading Specialty Pharmaceutical Company over the next couple of years, and with its operations in Europe PLIVA allows us the opportunity to expand this effort globally.  In addition, the strong development capabilities of PLIVA will provide the addition of many new generic pharmaceuticals to our expanding product portfolio - including generic versions of biotech pharmaceuticals.

The acquisition is a value-added and synergistic transaction for both PLIVA and Odyssey in the branded pharmaceutical activities.  Not only will PLIVA facilitate the very important strategy implemented by Odyssey of adding brand-name pharmaceuticals to its product portfolio, but Odyssey will offer its expanding line of brand-name products to PLIVA for markets outside the USA.

The bottom line: The changes that will occur at Sidmak/odyssey will be those that benefit you in the short and long term.

I would like to take this opportunity to thank you for your ongoing support of Sidmak and Odyssey.  I am confident that with our acquisition by PLIVA a win-win relationship will evolve for all.

Please feel free to contact the Sidmak/Odyssey sales department, or me, at 800-922-0547, should you have any questions or concerns relating to this important development.

Sincerely,

Paul D. Cottone                                                                                                                                                               President & CEO                                                                                                                                                              Sidmak Laboratories/Odyssey Pharmaceuticals


Back   |  Pharmcy News Releases  |  More Pharmacy News

 

Top News:

 

 

Letter from Mission Pharmacal 09/23/02

News From Geneva 09/01/02

Is something missing? from Blaine Pharmaceuticals 09/01/02

Pharmacy Jobs News from Pamida, Inc.09/01/02

GlaxoSmithKline is pleased to announce Wellbutrin SR 200mg 08/10/02

Mallinckrodt Pharmaceuticals announces important NDC Number Changes 07/29/02

Introducing Paxil CR, The Power of Balance 07/05/02

News from the Makers of Intranasal Bactroban 07/01/02

From Teva Neuroscience. Introducing Copaxone® Injection Pre-mixed, Pre-filled syringe 06/01/02

A turning point in my life: The death of my mother, my inspiration.

UIC - Distinguished Alumni Award

Notification of product tampering 05/04/02

Promotional info for Advair 04/10/02

Making a Difference in Senior Care 03/03/02

News From Andrx 03/07/02

Dementia & Alzheimers

Important Information From Amira Medical AtLast Blood Glucose System 1/15/02

Barr Lab Reports First Quarter 10/23/01

Maginex News 9/01/01

Andrx Corporation Purchased the Entex® line of cough and cold products 7/10/01

Barr Lab and Duramed announce Merger Agreement 6/29/01

Biovail Pharmaceuticals acquired marketing rights for Cardizem CD 6/15/01

New Dentaplex 6/12/01

Similar sounding drugs 6/11

Info from WellSpring 6/10

Important Notice from Roch Pharmaceuticals

 

Pharmacy Discussion Board | Focalin dosing flexibility with just the effective isomer.7/15/02

Pharmacy News This Week!  New convenient dosing tool and information for Augmentin ES-600

Rx Insurance Info News from PBMs | from Merck-Medco|Express Scripts, Inc. conducts periodic quality assurance pharmacy audits on the behalf of Excellus Health Plan 6/02 | News from Anthem Prescription Management | from AdvancePCS Clozaril Alert! 06/02/02

Pharmacy Jobs Get a New Pharmacy Job Today!

Independent Pharmacies dig in Post-Crescent Mar. 01, 2002

Eye Related Eye Disease Study from NEI and BAUSCH & LOMB 07-10-02

04/23/02 News from KINRAY 

Over 275 former Remo Independent Pharmacies have already placed orders with KINRAY. Kinray wishes to extend a healthy welcome and thank them for making KINRAY their "primary" Supplier. With over 2000 Independent Pharmacies, KINRAY is well on its way to the $ 3 Billion plateau.

ASCP American Society of Consultant Pharmacists ASCP: the only pharmacy organization dedicated to the care of an aging America. Workshops: Fundamentals of Consultant Pharmacy - Billing for Clinical Services - MDS Med-Guide - Pharmacy-Based Immunization Delivery. Call 1-800-355-2727, ext.113 for 2002 registration. or e-mail info@ascp.com

RPhLink Texas Pharmacists Register at www.txpharmacy.com.     

Pharmacy Press Releases | CPMP issued a positive reaffirming the favorable risk / benefit Profile of Meridia® (sibutramine) capsules for the treatment of obesity 07/15/02

Drug Information Drug Search | Health |

Medical Journals Books on line | Disease State Management info

Advertise with Us! Link here to place your Pharmacy Ad with us. Call 1-877-RPhLink

RPhLink North East Sheila P. Tucker, RPh Regional Director. Linking Pharmacists Together! When you need Pharmacy Coverage in the North East ( DC, DE, PA, MA, NY), For Relief or Permanent Placements Call Sheila at 302-366-8684. North East Pharmacists and Techs, Fax your Resume to Pharmacist Tucker. 1-800-774-4629.

Best  Pharmacy companies to work for , is your Pharmacy on the top list? Tell us how you feel!

Professional Care Judgement within an Ethical Framework

Pharmacist's Code of Ethics

 

Inez Victorian, PharmD - Clinical Pharmacy Services Handheld or Palm Operating System Devices for Clinical Pharmacy Practice

Article Submissions for Online RPhLink.com or Pharmacy Beat Magazine publications.

MRxI Corporation The Professional Pharmacy Technician Program

Call us at 1-877-RPhLink for our success stories and our client portfolio.

Upcoming Events for Pharmacists and Pharmacy Techs..

RPh  Just Link it!

Diabetic Control


© 2000 RPhLink.com  The Pharmaceutical Care Network! is designed and published by RPhLink. Inc. All Rights Reserved. Owned and Operated by Pharmacists for Pharmacists and Better Pharmaceutical Care.   RPhLink.com is designed by RPhs for Pharmacists & Pharmacy Techs.  For information use only! Disclaimer.

Back to Front Page   |   Link to  the lounge

General Pharmacy Classified | Pharmacy Antiques | Pharmacy Collectibles | Pharmacy Archives      

©2000 RPhLink.com The Pharmaceutical Care Network!

RPhLink.com |Front page | In Pharmacy this week | RxNews1 | RxNews2 | Pharmacy Jobs        

© 2000 RPhLink.com  The Pharmaceutical Care Network! is designed and published by RPhLink. Inc. All Rights Reserved. RPhLink.com is designed by RPhs for Pharmacists & Pharmacy Techs.  For information use only! Disclaimer.